Severe aortic stenosis is a life-threatening heart valve condition that restricts blood flow from the heart to the rest of the body. As the aortic valve becomes narrowed and stiff, the heart must work harder to pump blood, eventually leading to chest pain, breathlessness, dizziness, fainting, heart failure, and an increased risk of sudden cardiac death.
For many patients, especially those who are elderly or have multiple medical conditions, Transcatheter Aortic Valve Replacement (TAVR) offers an advanced minimally invasive alternative to conventional open-heart valve replacement surgery.
At Trinity Hospital & Heart Foundation, Basavanagudi, Bengaluru, Dr. B. G. Muralidhara, Senior Consultant Interventional Cardiologist, provides comprehensive evaluation for structural heart diseases and works with a multidisciplinary Heart Team to determine whether TAVR treatment for aortic stenosis is the most appropriate treatment option.
This guide explains everything about Transcatheter Aortic Valve Implantation, the TAVI procedure, patient eligibility, recovery, benefits, and long-term outcomes.
TAVR treatment for aortic stenosis is a minimally invasive procedure used to replace a severely narrowed aortic valve without performing conventional open-heart surgery.
Instead of removing the diseased valve, a specially designed artificial valve is delivered through a catheter and implanted within the damaged valve.
The procedure restores normal blood flow while reducing recovery time compared with traditional valve replacement surgery.
The aortic valve regulates blood flow from the left ventricle to the body’s largest artery (the aorta).
Over time, calcium deposits may accumulate on the valve, causing it to become thickened and narrowed.
As the condition progresses:
Without appropriate treatment, severe aortic stenosis carries a poor long-term prognosis.
Transcatheter Aortic Valve Implantation is the full medical term for the minimally invasive valve replacement procedure commonly known as TAVI or TAVR.
Unlike conventional surgery, the replacement valve is delivered through a catheter inserted into a blood vessel, most commonly through the femoral artery in the groin.
The new valve expands inside the diseased valve and immediately begins functioning.
This approach avoids opening the chest in many suitable patients.
What is the TAVI Procedure?
The TAVI procedure refers to Transcatheter Aortic Valve Implantation, a catheter-based technique used to replace a diseased aortic valve.
The procedure is performed in a specialized cardiac catheterization laboratory or hybrid operating room using advanced imaging guidance.
Benefits include:
Patient selection remains one of the most important factors for successful outcomes.
Patients often search using different spellings such as TAVR, TAVI, TAVAR, and TAVIR.
These terms generally refer to the same minimally invasive heart valve replacement procedure.
Although the terminology differs, the objective remains the same: replacing a severely diseased aortic valve without conventional open-heart surgery.
Not every patient with valve disease requires TAVR.
Candidates typically include patients with:
The final decision is made after evaluation by the multidisciplinary Heart Team.
Patients with severe aortic stenosis commonly experience:
Symptoms usually worsen gradually as the valve becomes more severely narrowed.
Before recommending TAVR treatment for aortic stenosis, detailed cardiac evaluation is necessary.
Investigations may include:
These investigations help determine valve anatomy, coronary artery disease, and procedural suitability.
Compared with conventional valve replacement surgery, Transcatheter Aortic Valve Implantation offers several advantages for carefully selected patients.
Benefits include:
The multidisciplinary Heart Team determines whether these benefits outweigh potential procedural risks for each patient.
Patients with complex structural heart disease require accurate diagnosis and individualized treatment planning.
At Trinity Hospital & Heart Foundation, Dr. B. G. Muralidhara provides comprehensive assessment for severe aortic stenosis and collaborates with experienced structural heart specialists and cardiac surgeons to recommend the most appropriate treatment strategy.
The TAVI surgery procedure is performed using advanced imaging guidance inside a cardiac catheterization laboratory or hybrid operating theatre.
The procedure generally involves:
The procedure usually takes between one and three hours, depending on the patient’s anatomy and clinical condition.
One of the major advantages of TAVR treatment for aortic stenosis is its relatively quick recovery compared with conventional surgery.
Patients are closely monitored after the procedure for:
Many patients begin walking within 24 hours and are discharged within a few days if recovery is uncomplicated.
Patients frequently ask about TAVR recovery time.
Although recovery varies from person to person, many patients experience:
Complete recovery depends on age, overall health, and any associated medical conditions.
Many patients want to know about life expectancy after TAVR procedure.
Long-term survival depends on several factors, including:
For appropriately selected patients, TAVR has been shown to improve survival, relieve symptoms, and significantly enhance quality of life.
Like any medical procedure, TAVR risks should be discussed before treatment.
Potential risks include:
The Heart Team carefully evaluates each patient to minimize these risks and maximize procedural success.
Post TAVR treatment focuses on protecting the new valve and optimizing long-term heart health.
Patients are advised to:
Regular echocardiography helps assess valve function during follow-up.
Patients may encounter the term HALT TAVR treatment, which refers to the management of Hypoattenuated Leaflet Thickening (HALT).
HALT is an imaging finding where mild clot formation affects the valve leaflets after TAVR.
Management may include:
Not all cases require intervention, and treatment decisions should be made by the Heart Team.
Although uncommon, infection involving the replacement valve can occur.
TAVR endocarditis treatment may include:
Early diagnosis improves treatment outcomes.
A small number of patients may develop leakage around the implanted valve.
Treatment of paravalvular leak after TAVR depends on its severity.
Management options include:
The Heart Team recommends treatment based on symptoms, imaging findings, and valve function.
At Trinity Hospital & Heart Foundation, patients benefit from a multidisciplinary Heart Team experienced in evaluating complex structural heart disease.
Our services include:
Every patient receives individualized care based on international structural heart disease guidelines and the latest evidence in minimally invasive valve therapy.
One of the most common questions patients ask is about the TAVR procedure cost. The overall cost depends on several factors, including the patient’s overall health, the complexity of the valve disease, the type of transcatheter valve used, pre-procedure investigations, hospital stay, and post-procedure care.
The treatment plan may include:
During your consultation, Dr. B. G. Muralidhara and the multidisciplinary Heart Team will explain the recommended treatment approach, expected recovery, and follow-up care before proceeding with the procedure.
Most patients experience a significant improvement in symptoms after successful TAVR treatment for aortic stenosis.
Patients are encouraged to:
Adopting these lifestyle changes helps improve long-term heart health and valve function.
Regular follow-up is essential to monitor the function of the replacement valve and detect any complications early.
Routine follow-up may include:
Patients should immediately report symptoms such as increasing breathlessness, chest discomfort, fever, swelling, or dizziness.
Patients visit Trinity Hospital & Heart Foundation for advanced structural heart disease treatment from across Bengaluru, including:
Trinity Hospital & Heart Foundation is centrally located in Basavanagudi, Bengaluru, making it convenient for patients travelling from different parts of the city.
Nearby landmarks include:
Patients can conveniently reach the hospital via Metro, BMTC buses, taxis, or private vehicles.
Successful Transcatheter Aortic Valve Implantation requires advanced imaging, precise procedural planning, and close collaboration between interventional cardiologists, cardiac surgeons, imaging specialists, anaesthesiologists, and intensive care teams.
At Trinity Hospital & Heart Foundation, Dr. B. G. Muralidhara works with a multidisciplinary Heart Team to provide comprehensive structural heart disease evaluation and personalized treatment planning.
Patients benefit from:
Every treatment plan is individualized according to international structural heart disease guidelines and the patient’s overall cardiovascular health.
Dr. B. G. Muralidhara is one of the senior interventional cardiologists at Trinity Hospital & Heart Foundation with more than 30 years of experience in diagnosing and treating coronary artery disease.
His patient-centered approach emphasizes accurate diagnosis, minimally invasive treatment whenever appropriate, and individualized long-term cardiac care.
If you have been diagnosed with severe aortic stenosis, experience breathlessness, chest pain, dizziness, fainting, or have been advised to consider TAVR treatment for aortic stenosis, early evaluation by an experienced structural heart team is essential.
Whether you require assessment for Transcatheter Aortic Valve Implantation, expert advice regarding the TAVI procedure, or comprehensive management of complex valve disease, Dr. B. G. Muralidhara and the multidisciplinary Heart Team at Trinity Hospital & Heart Foundation, Basavanagudi, provide advanced diagnosis, personalized treatment planning, and comprehensive long-term cardiac care.
Common questions and detailed answers about angioplasty procedures and recovery
TAVR treatment for aortic stenosis is a minimally invasive procedure that replaces a severely narrowed aortic valve without conventional open-heart surgery.
Transcatheter Aortic Valve Implantation is a catheter-based procedure in which a replacement valve is implanted inside the diseased aortic valve to restore normal blood flow.
Yes. The TAVI procedure (Transcatheter Aortic Valve Implantation) and TAVR (Transcatheter Aortic Valve Replacement) refer to the same minimally invasive valve replacement procedure.
Most patients recover faster than with open-heart surgery. Many begin walking within 24 hours and return to routine activities over the following few weeks, depending on their overall health.
The life expectancy after TAVR procedure depends on factors such as age, heart function, other medical conditions, and adherence to follow-up care. Many patients experience significant symptom relief and improved long-term survival.
Potential TAVR risks include bleeding, stroke, vascular complications, heart rhythm abnormalities, valve leakage, infection, kidney injury, and the possible need for a permanent pacemaker.
Post TAVR treatment includes medications, regular follow-up, echocardiography, blood pressure control, cardiac rehabilitation, and lifestyle modifications to maintain valve function and overall heart health.
HALT TAVR treatment refers to the management of Hypoattenuated Leaflet Thickening (HALT), an imaging finding involving reduced movement of valve leaflets that may require individualized medical management and follow-up.
TAVR endocarditis treatment usually involves hospitalization, intravenous antibiotics, blood culture testing, echocardiography, and Heart Team evaluation. Some patients may require additional interventions depending on the severity of the infection.
The treatment of paravalvular leak after TAVR depends on the severity of the leak. Mild leaks may only require monitoring, while moderate or severe leaks may be managed with catheter-based closure techniques, valve-in-valve procedures, or other interventions.
24 Hour Emergency Aid